Uterotonic Prophylaxis Trial (UPT)
A Randomized Controlled Trial of Methylergonovine Prophylaxis After Dilation and Evacuation Abortion
Sponsor: University of California, San Francisco
A PHASE4 clinical study on Hemorrhage, this trial is completed. The trial is conducted by University of California, San Francisco and has accumulated 11 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE4
-
Oct 2019 — Jan 2021 [monthly]
Completed PHASE4
-
Jun 2018 — Oct 2019 [monthly]
Completed PHASE4
-
Jun 2017 — Jun 2018 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Feb 2017 — Jun 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .